(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (NP (DT a) (NN literature) (NN review))) (VP (VBZ is) (VP (VBN made) (PP (IN for) (NP (NP (DT the) (JJ current) (NNS models)) (PP (IN of) (NP (NP (JJ glucose-insulin) (NNS dynamics)) (PP (IN of) (NP (NN type) (CD 2) (VBZ diabetes) (NNS patients))))))))) (. .))
(S (ADVP (NNS Afterwards)) (, ,) (NP (DT a) (NN model)) (VP (VBZ is) (VP (VBN proposed) (PP (IN by) (S (VP (VBG combining) (CC and) (VBG modifying) (NP (NP (DT some)) (PP (IN of) (NP (NP (DT the) (JJ available) (NNS models)) (PP (IN in) (NP (NN literature))))))))))) (. .))
(S (ADVP (RB Finally)) (, ,) (NP (DT a) (NN simulation) (NN study)) (VP (VBZ is) (VP (VBN provided) (S (VP (TO to) (VP (VB discuss) (NP (DT the) (JJ modified) (NN model))))))) (. .))
(S (NP (DT The) (NN model)) (VP (VBZ is) (VP (VBN proposed) (PP (IN as) (NP (NP (DT a) (NN candidate)) (SBAR (S (VP (TO to) (VP (VB be) (VP (VBN validated) (PP (IN with) (NP (JJ real) (NNS patients) (NNS data))) (PP (IN in) (NP (DT the) (NN future)))))))))))) (. .))
